RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - REGOLAZIONE DELL'ATTIVITA' DI FATTORI DI TRASCRIZIONE NEL DIFFERENZIAMENTO E NELLA TRASFORMAZIONE NEOPLASTICA.
• 2 - Ruolo dei recettori nucleari PPAR gamma nei meccanismi di cancerogenesi
• 3 - Apoptosi e terapia del cancro: caratterizzazione di nuovi meccanismi e nuove molecole modulatrici dell'apoptosi
• 4 - Vie di trasduzione e modifiche traduzionali e post-traduzionali nella protezione dall'apoptosi: disegno di nuove strategie terapeutiche antitumorali.
• 5 - Modulazione farmacologica in vitro e in vivo di oncogeni implicati nella tumorigenesi tiroidea.
• 6 - Studio sui rapporti tra autoimmunità tiroidea e tumori della tiroide
• 7 - CONTROLLO DEL CICLO CELLULARE DA LIGANDI DI RECETTORI NUCLEARI
• 8 - I membri della famiglia del TNF nella modulazione del differenziamento cellulare e dell'attività antitumorale
• 9 - Analisi funzionale ed implicazioni terapeutiche della eterogeneità cellulare in gliomi ad alto grado. Indagini su popolazioni selezionate in vitro con caratteri di multipotenza.
• 10 - Il colangiocarcinoma: approccio terapeutico basato su nuove acquisizioni di biologia cellulare e molecolare.

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • PATOLOGIA GENERALE
  • MEDICINA INTERNA
  • ENDOCRINOLOGIA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
• HUMAN NECESSITIES
  • MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]

Classificazione geografica

• Regione: Toscana

Bibliografia

Abbracchio MP,Burnstock G.(1998)Purinergic signalling: pathophysiological roles.Jpn J Pharmacol 78:113-45
Burnstock G.(2002)Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22:364-73
Corvilain B, Laurent E,Lecomte M,Vansande J, Dumont JE.(1994)Role of the cyclic adenosine 3',5'-monophosphate and the phosphatidylinositol-Ca2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. J Clin Endocrinol Metab 79:152-9
Farid NR,Shi Y,Zou M(1994)Molecular basis of thyroid cancer. Endocr Rev 15:202-32
Wagstaff SC,Bowler WB, Gallagher JA, Hipskind RA(2000) Extracellular ATP activates multiple signalling pathways and potentiates growth factor-induced c-fos gene expression in MCF-7 breast cancer cells. Carcinogenesis 21:2175-81
Hopfner M,Lemmer K, Jansen A, Hanski C, Riecken EO, Gavish M, Mann B, Buhr H, Glassmeier G, Scherubl H(1998) Expression of functional P2-purinergic receptors in primary cultures of human colorectal carcinoma cells. Biochem Biophys Res Commun 251:811-7
Ekokoski E,Webb TE,Simon J,Tornquist K(2001)Mechanisms of P2 receptor-evoked DNA synthesis in thyroid FRTL-5 cells.J Cell Physiol 187:166-75
Abbracchio MP,Burnstock G(1994)Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64:445-75
Khakh BS,Burnstock G,Kennedy C, King BF, North RA, Seguela P, Voigt M, Humphrey PP(2001) International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.Pharmacol Rev 53:107-18
Surprenant A,Rassendren F,Kawashima E,North RA, Buell G(1996)The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7).Science 272:735-8
Adinolfi E,Melchiorri L,Falzoni S,Chiozzi P, Morelli A, Tieghi A, Cuneo A, Castoldi G, Di Virgilio F, Baricordi OR(2002) P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 99:706-8
Baricordi OR,L Melchiorri,E Adinolfi, S Falzoni, P Chiozzi, G Buell and F Di Virgilio(1999).Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor. J Biol Chem 274:33206-33208
Di Virgilio F,Chiozzi P,Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, Baricordi OR(2001).Nucleotide receptors: an emerging family of regulatory molecules in blood cells.Blood 97:587-600
Di Virgilio F and Wiley JS(2002).The P2X7 receptor of CLL lymphocytes: a molecule with a split personality. Lancet 360:1898-1899
Duckett CS (2002).Apoptosis and NF-kappa B: the FADD connection. J Clin Invest 109:579-580
Ferrari D,Wesselborg S,Bauer MK, Schulze-Osthoff K(1997). Extracellular ATP activates transcription factor NF-kappaB through the P2Z purinoreceptor by selectively targeting NF-kappaB p65. J Cell Biol 139:1635-1643
Ferrari D, Stroh C,Schulze-Osthoff K(1999).P2X7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells. J Biol Chem 274:13205-13210
Horsley V and Pavlath GK (2002).NFAT: ubiquitous regulator of cell differentiation and adaptation. J Cell Biol 156:771-774
Karin M and Lin A (2002). NF-kappaB at the crossroads of life and death.Nat Immunol 3:221-227
Kiani A, Rao A, Aramburu J(2000).Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 12:359-372
Kneitz C, Goller M, Tony H, Simon A, Stibbe C, Konig T, Serfling E, Avots A(2002).The CD23b promoter is a target for NF-AT transcription factors in B-CLL cells. Biochim Biophys Acta 1588:41-47
Kondo E, Harashima A, Takabatake T, Takahashi H, Matsuo Y, Yoshino T, Orita K, Akagi T(2003).NF-ATc2 induces apoptosis in Burkitt's lymphoma cells through signaling via the B cell antigen receptor.Eur J Immunol 33:1-11
Macian F, Lopez-Rodriguez C, Rao A(2001).Partners in transcription: NFAT and AP-1.Oncogene 20:2476-2489
North RA (2002)The molecular physiology of P2X receptors. Physiol Rev 82:1013-67
Ralevic V and Burnstock G(1998).Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492
Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA, Crabtree GR(1988). Identification of a Putative regulator of early T cell activation genes. Science 241:202-205
Starenki D, Namba H, Saenko V, Ohtsuru A, Yamashita S(2004). Inhibition of nuclear factor-kappaB cascade potentiates the effect of a combination treatment of anaplastic thyroid cancer cells. J Clin Endocrinol Metab 89:410-418
Tapia G, Fernandez V, Varela P, Cornejo P, Guerrero J, Videla LA(2003).Thyroid hormone-induced oxidative stress triggers nuclear factor-kappaB activation and cytokine gene expression in rat liver. Free Radic Biol Med 35:257-265
Valen G, Yan ZQ, Hansson GK(2001).Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38:307-314
von Kugelgen I and Wetter A(2000).Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol 362:310-323
Wang CY, Zhong WB, Chang TC, Lai SM, Tsai YF(2002). Tumor necrosis factor alpha induces three-dimensional cytomorphologic differentiation of human anaplastic thyroid carcinoma cells through activation of nuclear factor kappaB. Cancer 95:1827-33.
Wiley JS, Chen R, Jamieson GP(1993). The ATP4+ receptor-operated channel (P2Z class) of human lymphocytes allows Ba++ and ethidium+ uptake: inhibition of fluxes by suramin. Arch Biochem Biophys 305:54-60.
Yang J, Rothermel B, Vega RB, Frey N, McKinsey TA, Olson EN, Bassel-Duby R, Williams RS(2000). Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res 87:E61-E68.
Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A (2004). A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135:139-148.
Monzani F, Caraccio N, Iacconi P, Faviana P, Dardano A, Basolo F,et al (2003). Prevalence of cancer in follicular thyroid nodules: is there still a role for intraoperative frozen section analysis? Thyroid 13:389-394.
Grieco M, Cerrato A, Santoro M, Fusco A, Melillo RM, Vecchio G (1994). Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo. Oncogene 9:2531-2535.
Bongarzone I, Fugazzola L, Vigneri P, Mariani L, Mondellini P, Pacini F,et al (1996). Age-related activation of the tyrosine kinase receptor proto-oncogene ret and ntrk 1 in papillary thyroid carcinoma. J Clin Endocrinol Metab 81:2006-2009.
Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, Basolo F, Demidchik EP, Miccoli P, Pinchera A, Pacini F (2001). Ret/ptc rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 86:3211-3216.
Basolo F, Pisaturo F, Pollina L, Fontanini G, Elisei R, Molinaro E, et al (2000). N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression. Thyroid 10:19-23.
Segev DL, Umbricht C, Zeiger MA (2003). Molecular pathogenesis of thyroid cancer. Surg Oncol 12:69-90.
Solini A, Chiozzi P, Morelli A, Fellin R, Di Virgilio F Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. (1999). J Cell Sci 112:297-305.
Solini A, Chiozzi P, Morelli A, Passaro A, Fellin R, Di Virgilio F(2003). Defective P2Y purinergic receptor function: A possible novel mechanism for impaired glucose transport. J Cell Physiol 197:435-444.
Falzoni S, Munerati M, Ferrari D, Spisani S, Moretti S, Di Virgilio F (1995). The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest 5:1207-1216.
Ferrari D, Los M, Bauer MK, Vandenabeele P, Wesselborg S, Schulze-Osthoff K (1999). P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Let 19:71-75.

Parole Chiave

ATP EXTRACELLULARE; NEOPLASIE TIROIDEE; RECETTORI PURINERGICI; ONCOGENI; CITOCHINE; CALCIO INTRACELLULARE